ALK and non-small cell lung carcinoma: Advanced, anaplastic lymphoma kinase (ALK) – positive Non Small Cell Lung Cancer (NSCLC) defines a specific molecular subtype among NSCLCs which is nowadays regularly treated with ALK inhibitors (ALKi).